ATE257472T1 - Dimesylatsalze von neuropeptiden und liganden - Google Patents

Dimesylatsalze von neuropeptiden und liganden

Info

Publication number
ATE257472T1
ATE257472T1 AT97910602T AT97910602T ATE257472T1 AT E257472 T1 ATE257472 T1 AT E257472T1 AT 97910602 T AT97910602 T AT 97910602T AT 97910602 T AT97910602 T AT 97910602T AT E257472 T1 ATE257472 T1 AT E257472T1
Authority
AT
Austria
Prior art keywords
neuropeptides
ligands
dimesylate
salts
dimesylate salts
Prior art date
Application number
AT97910602T
Other languages
English (en)
Inventor
Douglas J M Allen
Lyle R Brostrom
Alireza S Kord
Laurie A Whipple
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE257472T1 publication Critical patent/ATE257472T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT97910602T 1996-11-26 1997-11-19 Dimesylatsalze von neuropeptiden und liganden ATE257472T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3181596P 1996-11-26 1996-11-26
PCT/IB1997/001465 WO1998023603A1 (en) 1996-11-26 1997-11-19 Dimesylate salts of neuropeptide y ligands

Publications (1)

Publication Number Publication Date
ATE257472T1 true ATE257472T1 (de) 2004-01-15

Family

ID=21861551

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97910602T ATE257472T1 (de) 1996-11-26 1997-11-19 Dimesylatsalze von neuropeptiden und liganden

Country Status (23)

Country Link
US (1) US5914329A (de)
EP (1) EP0944611B1 (de)
JP (1) JP3120861B2 (de)
AP (1) AP9701148A0 (de)
AR (1) AR010304A1 (de)
AT (1) ATE257472T1 (de)
AU (1) AU4792497A (de)
BR (1) BR9713538A (de)
CA (1) CA2272927C (de)
DE (1) DE69727155T2 (de)
DK (1) DK0944611T3 (de)
ES (1) ES2213207T3 (de)
GT (1) GT199700123A (de)
HN (1) HN1997000154A (de)
HR (1) HRP970640A2 (de)
ID (1) ID18964A (de)
MA (1) MA26450A1 (de)
PA (1) PA8441701A1 (de)
PE (1) PE17099A1 (de)
PT (1) PT944611E (de)
TN (1) TNSN97191A1 (de)
WO (1) WO1998023603A1 (de)
ZA (1) ZA9710587B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001053477A1 (en) * 2000-01-20 2001-07-26 Baylor College Of Medicine Methods and compositions for control of bone formation via modulation of neuropeptide y activity
US20060165683A1 (en) 2001-12-05 2006-07-27 Gerard Karsenty Methods and compositions for control of bone formation via modulation of sympathetic tone
EP1470228B1 (de) 2002-01-09 2006-03-29 Arexis AB Mutationsnachweis
PT1701722E (pt) * 2004-11-23 2009-12-10 Dong Wha Pharm Co Ltd Sal do ácido n-hidroxi-4-{5-[4-(5-isopropil-2-metil-1,3-tiazol- 4-il)fenoxi]pentoxi}benzamidina-2-metanossulfónico
WO2006108218A1 (en) * 2005-04-15 2006-10-19 Regenertech Pty Limited Use of neuropeptide y (npy) and agonists and antagonists thereof for tissue regeneration

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL321136A1 (en) * 1994-11-07 1997-11-24 Pfizer Some substituted derivatives of bencylamine as a new class of specific ligands of neuropeptide y1

Also Published As

Publication number Publication date
JP3120861B2 (ja) 2000-12-25
AP9701148A0 (en) 1998-01-31
ID18964A (id) 1998-05-28
DE69727155T2 (de) 2004-07-08
MA26450A1 (fr) 2004-12-20
PT944611E (pt) 2004-04-30
DK0944611T3 (da) 2004-04-13
BR9713538A (de) 2000-03-21
US5914329A (en) 1999-06-22
JP2000505110A (ja) 2000-04-25
ES2213207T3 (es) 2004-08-16
HN1997000154A (es) 1999-02-09
AU4792497A (en) 1998-06-22
CA2272927C (en) 2003-02-04
EP0944611B1 (de) 2004-01-07
HRP970640A2 (en) 1998-10-31
EP0944611A1 (de) 1999-09-29
PA8441701A1 (es) 2000-05-24
PE17099A1 (es) 1999-02-19
ZA9710587B (en) 1999-05-25
WO1998023603A1 (en) 1998-06-04
CA2272927A1 (en) 1998-06-04
GT199700123A (es) 1999-05-19
AR010304A1 (es) 2000-06-07
TNSN97191A1 (fr) 2005-03-15
DE69727155D1 (de) 2004-02-12

Similar Documents

Publication Publication Date Title
DE69736664D1 (de) Segmentierung und wiederzusammensetzung von minizellen
DE69422791D1 (de) Sendung und Empfang von Programminformation
DE69533361D1 (de) Umsetzung von kohlenwasserstoffen
DE69813233D1 (de) Hydrocyanierung von diolefinen und isomierung von nicht-konjugierten 2-alkyl-3-monoalkennitrilen
DE69727218D1 (de) Einschluss komplexe von aryl-heterokyhlishe salzen
ATA116194A (de) Fluxbitumen und bitumenemulsion
NO972625L (no) Fibrin-tetningsapplikator
DE69728779D1 (de) Entfernung von fältchen
ID19422A (id) Piridina dan bifenil tersubstitusi
DE69841295D1 (de) Regenerierung von In-Phase- und Quadratursignalen
ATE261935T1 (de) Neue metformin salze und verfahren
DE69718231D1 (de) Schnitt von aufgezeichnetem Material
DE69509714D1 (de) Zerstörung von Unterwasser-Gegenständen
DE69501493D1 (de) Entfernung von Feuchtigkeit und Passivierung von Oberflächen
DE69702805D1 (de) Vielseitige Massstabsveränderung von Zeichnungen
DE59507427D1 (de) Mischkristalle und feste Lösungen von 1,4-Diketopyrrolopyrrolen
ID28261A (id) Alat penghancur dan metoda penghancuran
EP0996433A4 (de) Behandlungsverfahren von lactosylceramidbedingten zuständen
ID16889A (id) Senyawa turunan alkilaminobenzotiazol dan benzoksazol
DE69517289D1 (de) Verfahren zur Aktivierung von Ton und aktiviertem Ton
DE69506350D1 (de) Erfassung des Zustandes von Aufzeichnungsträgern
ID18456A (id) Produksi-bersama 6-aminokapronitril dan heksametilenadiamina
NO992104D0 (no) Isokinoloner
DE69814100D1 (de) Verschluss von absorbierenden artikeln
DE69717677D1 (de) Koproduktion von perfluormethylperfluorvinylether und perfluorethylperfluorvinylether

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0944611

Country of ref document: EP

REN Ceased due to non-payment of the annual fee